S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:BALY

Bally's (BALY) Stock Price, News & Analysis

$14.50
+0.50 (+3.57%)
(As of 04/19/2024 ET)
Today's Range
$13.74
$14.52
50-Day Range
$9.75
$14.00
52-Week Range
$7.28
$18.66
Volume
1.15 million shs
Average Volume
491,548 shs
Market Capitalization
$581.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.86

Bally's MarketRank™ Stock Analysis

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
2.5% Upside
$14.86 Price Target
Short Interest
Healthy
8.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of Bally
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.73) to ($3.07) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.57 out of 5 stars

Consumer Discretionary Sector

238th out of 262 stocks

Hotels & Motels Industry

24th out of 26 stocks

BALY stock logo

About Bally's Stock (NYSE:BALY)

Bally's Corporation operates as a casino-entertainment company. It owns and manages casinos across 10 states, a golf course in New York, a horse racetrack in Colorado, and has access to OSB licenses in 18 states. It also owns Bally's Interactive International, an online gaming operator; Bally Bet, a sports betting platform; and Bally Casino, an iCasino platform. The company's casino operations include slot machines, table games, and hotel rooms. It also has rights to developable land in Las Vegas. The company was formerly known as Twin River Worldwide Holdings, Inc. and changed its name to Bally's Corporation in November 2020. Bally's Corporation was incorporated in 2004 and is headquartered in Providence, Rhode Island.

BALY Stock Price History

BALY Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Bally's Atlantic City Celebrates 45th Anniversary
Bally's Atlantic City Celebrates 45th Anniversary
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Bally's hires advisors to evaluate takeover bid
Bally's 'polarizing issue' has been Chicago, says Macquarie
BALY Dec 2024 5.000 put
BALY Dec 2024 10.000 call
See More Headlines
Receive BALY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bally's and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
4/19/2024
Next Earnings (Confirmed)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Hotels & motels
Sub-Industry
N/A
Fax
N/A
Employees
10,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.86
High Stock Price Target
$30.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+2.5%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Net Income
$-187,500,000.00
Pretax Margin
-7.58%

Debt

Sales & Book Value

Annual Sales
$2.45 billion
Cash Flow
$2.66 per share
Book Value
$13.94 per share

Miscellaneous

Free Float
28,503,000
Market Cap
$581.31 million
Optionable
Optionable
Beta
2.08
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Robeson Mandela Reeves (Age 40)
    CEO & Director
    Comp: $2.32M
  • Mr. George T. Papanier (Age 66)
    President & Director
    Comp: $2.08M
  • Mr. Marcus Glover (Age 48)
    Executive VP & CFO
    Comp: $913.89k
  • Ms. Kimberly Marie Barker Lee (Age 56)
    Executive VP & Chief Legal Officer
    Comp: $939.16k
  • Mr. Craig L. Eaton (Age 59)
    President of Rhode Island Operations & Corporate Secretary
    Comp: $690.04k
  • Charles Diao
    Senior VP of Finance & Corporate Treasurer
  • Jeff Chalson
    Vice President of Corporate Development & Strategy

BALY Stock Analysis - Frequently Asked Questions

Should I buy or sell Bally's stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bally's in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BALY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BALY, but not buy additional shares or sell existing shares.
View BALY analyst ratings
or view top-rated stocks.

What is Bally's' stock price target for 2024?

6 equities research analysts have issued twelve-month target prices for Bally's' shares. Their BALY share price targets range from $10.00 to $30.00. On average, they anticipate the company's stock price to reach $14.86 in the next year. This suggests a possible upside of 2.5% from the stock's current price.
View analysts price targets for BALY
or view top-rated stocks among Wall Street analysts.

How have BALY shares performed in 2024?

Bally's' stock was trading at $13.94 at the beginning of the year. Since then, BALY stock has increased by 4.0% and is now trading at $14.50.
View the best growth stocks for 2024 here
.

Are investors shorting Bally's?

Bally's saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 2,190,000 shares, a decrease of 8.4% from the February 29th total of 2,390,000 shares. Based on an average daily trading volume, of 483,600 shares, the days-to-cover ratio is currently 4.5 days. Currently, 9.6% of the company's shares are sold short.
View Bally's' Short Interest
.

When is Bally's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our BALY earnings forecast
.

How can I listen to Bally's' earnings call?

Bally's will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Bally's' earnings last quarter?

Bally's Co. (NYSE:BALY) released its quarterly earnings data on Wednesday, February, 21st. The company reported ($0.86) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.31. The company earned $611.67 million during the quarter, compared to analyst estimates of $626.62 million. Bally's had a negative trailing twelve-month return on equity of 17.92% and a negative net margin of 7.05%.

What ETFs hold Bally's' stock?
What guidance has Bally's issued on next quarter's earnings?

Bally's issued an update on its FY 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.5 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion.

How do I buy shares of Bally's?

Shares of BALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BALY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners